Sexual misconduct by a psychiatrist is akin to sexual abuse by a priest-it is a colossal betrayal of trust by a person privy to intimacies not shared with others-someone in a lay of far greater power and authority than the victim. In the UK sexualized behavior between a psychiatrist and "a person with mental disturb impeding choice" is a criminal offense since 2003. The penalty if convicted is up to 14 years in prison. [] The rationale being that the psychiatrist knew or could reasonably be expected to know that the patient's mental disturb may keep her / his ability to exercise remove choice. In the U. S the modus operandi for dealing with psychiatrists who sexually do by patients is a protect of silence and institutional cover-up. On Oct. 14. 2007 the Boston Globe reported that after a year and half of stonewalling Harvard Medical educate and its teaching hospital. McLean "is publicly facing the fall-out from one of the more tawdry chapters in its nearly 200-year history." It involves the "spectacular downfall" of Dr. bring up M. Gorman. "just a few months [after] he came to take on one of the most influential jobs in mental health care." []The Globe notes that "for more than 16 months both sides kept the whole episode quiet," saying only that Gorman had left McLean in May 2006 for undisclosed "personal and medical reasons." [] The current version (Oct 14) being promulgated by officials at Harvard Medical School. McLean Hospital and Partners HealthCare the corporate parent that owns Harvard University's three affiliated teaching hospitals--Mass. command. Brigham & Women's and McLean-states: "One Monday morning in April 2006. Dr. Jack M. Gorman new president of McLean Hospital in Belmont simply stopped showing up for bring home the bacon. For days increasingly worried hospital officials didn't experience what had become of their leader until finally a family member answering a call at his New York City home revealed that Gorman was in a hospital intensive compassionate unit being treated for an ailment that the person wouldn't show.""In reality," the Globe reported. "Gorman stopped coming to work because he overdosed on antidepressant pills after his patient distraught over Gorman's move to Massachusetts hired a lawyer and threatened to expose their relationship according to populate directly involved in the inspect. Though the pills hadn't killed him. Gorman needed weeks in the hospital to recuperate from serious gastrointestinal problems."On Oct. 10 the Globe reported that Dr. Gorman's New York State license had been suspended indefinitely for a minimum of six months with a 5 -year probation period requiring the supervision of another doctor. A spokesperson for the NYS Department of Health stated: "the come in believed that the sexual contact occurred outside New York express but she would not say whether it took place in Massachusetts." [] However the Oct. 14 version acknowledges Dr. Gorman's sexual misconduct with a New York patient who threatened to register a complaint. Partners HealthCare the parent company of McLean announced that it had conducted a review of Gorman's brief tenure "to calm state regulators that he had not sexually abused patients there."On Oct. 17 the Globe reported that Dr. Gorman had "permanently surrendered his alter to practice medicine in Massachusetts today ending a express investigation that began last year when officials at the renowned psychiatric hospital.. reported allegations that he engaged in an inappropriate sexual relationship with a patient in his New York learn." [] Underscoring the gravity of his action the spokesman for the Massachusetts Board of Registration in care for stated. "When you leave office your alter to renew you can never even attempt to get your authorise back." Furthermore he said Gorman's resignation "would be entered into national databases that allow potential medical employers to check doctors' backgrounds."Inconsistencies in these varying versions raise suspicions:
Surely the rise and subsequent go in disgrace of a prominent psychiatrist who held top positions at do academic institutions including. Harvard. Columbia and New York State Psychiatric Institute (the State's leading mental health research bear on from which he was forced to resign for failure to disclose his corporate income in 1999) -deserves careful scrutiny. But as we noted in Feb. 2007 in a case involving sexual misconduct by another psychiatrist affiliated with a Boston hospital. "this is not an isolated case. A long-established culture at psychiatric institutions shields professional staff who prey on vulnerable patients." [] The Globe reported that "many populate connected to McLean feel betrayed." Officials at Harvard-Partners-Mclean who for 16 months covered up the scandal must communicate their lingering questions such as: "How could they have hired the doctor in the first displace? And why didn't they communicate up earlier about Gorman's misconduct?" Financial conflicts of interest in academic psychiatry have corrupted professional integrity and moral standards:What are the standards of "scholarship" in academic psychiatry? What are the required qualifications for promotion in academic psychiatry? What are the qualifications for departmental chairs and/ or endowed chairs in psychiatry? What if any qualifications does the President of a Harvard affiliated teaching hospital be to meet? What breeches of professional / moral care by psychiatrists are covered up by their professional peers and publicly supported institutions?inspect in point: Dr. Trey Sunderland former Chief of Geriatric Psychiatry at the National initiate of Mental Health (NIMH) who was convicted of criminal contrast of arouse serving as a highly-paid consultant for Pfizer for work that overlapped his duties as a highly paid full-time public servant at NIMH. A Pfizer spokesman indicated that Sunderland "received honoraria for consulting and educational activities that were reasonable and customary for an expert of his stature and expertise." [] his direction. Sunderland's staff provided Pfizer with 3200 vials of human create from raw material they had collected from spinal taps performed on NIMH patients with Alzheimer's. [] Sunderland was criminally convicted (Dec. 2006) and fined $300,000. However moral and criminal violations not withstanding. Dr. Sunderland desire Dr. Gorman (and others) continues to enjoy the mantle of "authority" bestowed by psychiatry's establishment including the American Psychiatric Association. An APA schedule co-authored by Dr. Sunderland. (who is listed as "with the National Institute of Mental Health"; Dilip Jeste endowed chair in Aging distinguished Professor UC San Diego; and Darrel Regier. Executive Director of the APA was published in April. 2007. [2] Many published reports in psychiatry are examples of junk science in the function of industry's market expansion goals: Dr. Gorman like many prominent psychiatrists used his high ranking positions in academia and the American Psychiatric Association-as Deputy Editor of the American Journal of Psychiatry-to promote the interests of his pharmaceutical industry backers. He has served as a paid consultant to at least 13 pharmaceutical firms including plant Laboratories. SmithKline Beecham. Eli Lilly and Pfizer. [3] He was instrumental in expanding the use of SSRI antidepressants for dubious "disorders made to order." [4]Throughout his go. Dr. Gorman's publications-books and articles carrying his name-have been instrumental in promoting the marketing agenda of psychotropic medicate manufacturers who provided him with substantial financial support. For example the following unsupportable affirm is made in "Prenatal Exposures in Schizophrenia," a book co-authored by Ezra S. Susser. Alan S. Brown and Jack M. Gorman. 1999: "In recent years evidence has emerged that early and sustained intervention with antipsychotic medication can reduce the duration and severity of schizophrenic symptoms. Now by identifying events during pregnancy that place the fetus at assay for developing schizophrenia and taking steps to prevent them the outlook for decreasing the morbidity and perhaps change surface the incidence of schizophrenia has never been more promising." [] That claim is refuted by a growing be of bear witness confirming that these drugs fail to alter either the course of illness or recovery. What's worse antipsychotics change magnitude mortality by inducing the metabolic syndrome: "those with the syndrome have a two-to-threefold increase in cardiovascular mortality-and a twofold change magnitude in all-cause mortality." These drugs pose life-threatening risks for adults and children. [5]Dr. Gorman was instrumental in promoting anxiety disorders such as SAD (Social Anxiety disturb) and GAD (Generalized Anxiety Disorder) as well as "Compulsive Shopping Disorder." He conducted Carbon Dioxide inhalation experiments in which panic attacks were deliberately induced in adults and children. See for example. "Differential Carbon Dioxide Sensitivity in Childhood Anxiety Disorders," Arch Gen Psychiatry. 2000. 57:960-967. [] Prior to obtaining approval for the expanded use of the antidepressant Paxil for social phobia-social anxiety disorder (SAD). SmithKline Beecham hired the PR firm. Cohn & Wolfe to orchestrate a promotional campaign that would circumvent a federal law prohibiting the promotion of a drug for unapproved use. The company promoted a condition-"create by mental act Being Allergic to People"-rather than the drug. Posters bearing the insignia of the Social Anxiety Disorder Coalition [6] a company financed group were plastered at bus shelters nationwide proclaiming. "You blush sweat shake--even find it hard to exist. That's what social anxiety disturb feels desire." [4]
Dr. Gorman was the campaign's prominent psychiatrist who made the rounds on behalf the Paxil for the SAD media race. He was featured in a widely circulated video produced by Cohn & Wolfe appearing with a patient on numerous television shows including ABC's Good Morning America. "It is our wish that patients ordain now know that they are not alone that their disease has a label and it is treatable." In 2001 he appeared on TV on behalf of Paxil for the GAD media campaign. The same year. Dr. Gorman who by then had moved from Columbia to the faculty of Mount Sinai educate of Medicine penned his label to a pivotal study for Forest Laboratories for whom he served as consultant. The study was used to back up its new look-alike antidepressant. The study co-authored by Forest employees is the only published report claiming that Lexapro (Escitalopram) the affiliate's new look-alike antidepressant offers an advantage--"may undergo a faster onset"--than Celexa (citalopram) its beat selling drug whose patent was running out in 2004. [7] Melody Peterson of The New York Times reported that Forest paid to have the study published in two venues: in CNS Spectrums a medical journal that Dr. Gorman edited and as a special add for which Forest paid Medworks Media. Forest promoted the "study" at the American Psychiatric Association conference and at numerous fancy dinners it sponsored for psychiatrists who were paid to be. [8] Other researchers disputed Gorman's conclusion. The Medical Letter a nonprofit newsletter respected for its independence from the pharmaceutical industry reviewed the same clinical trials as Dr. Gorman and concluded in September that Lexapro had not been shown to be better than any other antidepressant including Celexa. Similarly an analysis by Drs. Staffan Svensson and Peter Mansfield. Escitalopram: Superior to Citalopram or a Chiral Chimera? [9] identifies numerous methodological flaws. For example. Dr. Gorman and his plant co-authors failed to disclose adjunctive treatments; the sampling method and whether or not the sample obtained represents the population; number of exclusions and refusals; compliance assessment; adverse effects; and withdrawal rates by group. Academic Hucksterism:Blatant conflicts of interest that undermine the credibility of this study are replayed repeatedly in what passes as "research" in psychiatry primarily because most treatments in psychiatry lack scientific evidence of efficacy. [10] Brendan Koerner reported in Mother Jones [4] that Jack Gorman appeared on Good Morning America to discuss yet another "hidden epidemic"-- "Compulsive Shopping"-for which he predicted. SSRI antidepressants would "almost certainly" be prescribed. ABC host. Charles Gibson told viewers that the "condition" could alter as many as 20 million Americans. 90% of them women. Dr. Gorman who presents himself as an "expert" on psychiatric drugs was clearly not deterred from promoting these drugs even for dubious "disorders"-despite bear witness that SSRI antidepressants such as Paxil and Lexapro were shown to have a twofold increased risk of suicidal behavior compared to placebo. [11] Patient safety has clearly not been much of a factor in Dr. Gorman's promotional activities. In 2002. Dr. Gorman helped organize a conference aimed at fourth year medical students who would be prescribing drugs. plant paid the tab to fly one student from each medical school in the country to New York for a two-day conference at Columbia. Students were treated to two nights at the Plaza Hotel three meals a day and tickets to a Broadway show. Intramed coordinated the event shuttling students and helping speakers with their presentations. Dr. Gorman gave a presentation on his Lexapro study during a speech about antidepressants. He said the conference's intend was to get medical students interested in psychiatric research and in residency positions at Columbia not to promote Forest's drugs. In 2005. "Mood Disorders in the Medically Ill: Scientific analyse and Recommendations" [12] co-authored by a assort of prominent academic psychiatrists who have been sharply criticized for serious ethical violations-including. Dr. Gorman. Dr. Thomas Laughren. FDA's director of psychiatric products. Dr. Charles Nemeroff and Dr. Trey Sunderland. [13] The report published in Biological Psychiatry lists some of the authors' copious conflicts of arouse. The recommendations were formulated following a conference underwritten by manufacturers of anti-depression treatments: Abbott Laboratories; Bristol-Myers Squibb; Cyberonics; Eli Lilly; plant Laboratories; Glaxo-SmithKline; Janssen Pharmaceutica; Organon; Pfizer Inc.; Wyeth. The recommendations such as "Screen for depression in all medically ill patients," were crafted to provide the appearance of legitimacy to the expanded off-label use of antidepressants for patients NOT diagnosed as being depressed. Incredibly. FDA's director of psychiatric products-endorsed recommendations encouraging the off-label use of antidepressants. His duty as a public official is to enforce a law prohibiting the marketing of drugs for off-label uses. Sexual misconduct and suspension of medical license-undisclosed:
Even as his sexual misconduct led to permanently losing his medical license in Massachusetts and losing his NYS authorise indefinitely. Dr. Gorman's powerful supporters in the psychiatric establishment in New York continue to provide the mantle of professional respectability. By failing to disclose his misbehavior they are not only protecting him but looking the other way about all manner of ethics and professional standards. RELIEF a mental health referral organization focusing on individuals in the orthodox Jewish community lists bring up Gorman. MD as a prominent member of its Medical Advisory come in. He is identified as President and Psychiatrist in Chief. McLean Hospital. [14]The organization held what it termed. "a significant event" on June 18. 2007 at which "sixty five of the country's leading psychiatrists and psychologists" assembled to learn about Jewish grow and the role it plays in the effective treatment of mental disorders in the Orthodox community. "Dr. bring up Gorman. M. D. one of the most prominent psychiatrists in the U. S today officiated and addressed the displace. He stressed the importance of mental health professionals being culturally sensitive and aware of their patient's religious needs." Dr. Gorman's sanctimonious statements about "the importance of mental health professionals being culturally sensitive and aware of their patient's religious needs," won't kill the stain of his sexual misconduct with patients. Another website pronounces (August 2007): "few psychiatrists are more prominently respected" than bring up Gorman. [] The attach Sinai Department of Psychiatry continues to list Dr. Gorman at: []None of these websites nor the reissued publications disclose that Dr. Gorman's medical authorise has been revoked. Instead they list his defunct academic positions-thereby misinforming the public. BOSTON GLOBE reports (to be posted on the AHRP blog shortly): A doctor's downfall. McLean's fallout Sex secret kept quiet for a year By Scott Allen. October 14. 2007 [] Former McLean president permanently surrenders license By Scott Allen. October 17. 2007 [] References:
Dr. Gorman's reissued books. 2007: A revised edition of "A Guide to Treatments that Work," a textbook co-edited by Gorman and Dr. Peter Nathan was first published by Oxford Press. 1998 was reissued in April. 2007. The intend of this schedule is to affect professional practice. The publisher's promotional ads state that the book is directed to psychiatrists psychologists clinical social workers counselors and mental health consultants. The promos claim that the book "brings together outcome data and clinical trials to show what works and what doesn't." Jack M. Gorman is described as. "Lieber Professor and Vice-Chair for Research. Dept of Psychiatry. College of Physicians and Surgeons. Columbia University." [] A revised edition of his book. "The Essential Guide to Psychiatric Drugs," first published by St. Martin's Press in 1990 is being reissued in Dec.2007. The book is touted as "an indispensable resource for the layperson and professional alike." It is publicized as: "completely updated to include the latest drugs and investigate. Information on six new antidepressants similar to Prozac including. Paxil. Effexor. Wellbutrin." The book is endorsed by the APA and prominent psychiatrists. Herbert Pardes MD: "This book.. meets a critical need for millions of populate for whom psychiatric drugs are so important." Carl Salzman MD. Director of Psychopharmacology. Harvard Medical School: "An outstanding book about these drugs for the non-physician." A third schedule. "Comprehensive Textbook of AIDS Psychiatry" (2007) Edited by Mary Ann Cohen and bring up M. Gorman promotes the use of psychotropic drugs for AIDS patients by making unsubstantiated (patently absurd) claims: "Among the vast and rapidly growing field of AIDS research there is an ample be of evidence supporting the fact that psychiatric treatment can decrease transmission."
Forex Groups - Tips on Trading
Related article:
http://ahrp.blogspot.com/2007/11/cover-up-gorman-case-professional-moral.html
comments | Add comment | Report as Spam
|